俄勒冈州 的 肺癌 临床试验
俄勒冈州 有 31 项针对 肺癌 的研究正在招募参与者。
俄勒冈州 的城市
官方研究文本（英文）
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Providence Portland Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月13日 · NCT07063745Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Providence Cancer Institute Franz Clinic, Portland
- Providence St. Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT07100080Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Providence Hood River Memorial Hospital, Hood River
- Providence Newberg Medical Center, Newberg
- Providence Willamette Falls Medical Center, Oregon City
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06498635Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Good Samaritan Hospital, Corvallis
- Three Rivers Community Hospital, Grants Pass
- Asante Rogue Regional Medical Center, Medford
- 以及另外 5 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
招募中3 期
70 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06096844A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Oregon Health and Science University ( Site 0052), Portland
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT06312137A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Oregon Health and Science University, Portland
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月5日 · NCT06793215cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
招募中观察性研究欢迎健康志愿者
40 岁及以上 · 所有性别 · 更新于 2026年11月4日 · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 以及另外 7 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年11月4日 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Saint Charles Health System, Bend
- Providence Newberg Medical Center, Newberg
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月4日 · NCT04181060A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Oncology Associates of Oregon, Eugene
- Asante Rogue Regional Medical Center, Medford
- Providence Portland Medical Center, Portland
- 以及另外 2 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年11月4日 · NCT06119581A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Oregon Health and Science University, Portland
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月22日 · NCT07154290Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- OHSU Knight Cancer Institute, Portland
招募中4 期
18 岁及以上 · 所有性别 · 更新于 2026年10月13日 · NCT07405086Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Providence Portland Medical Center, Portland
- Providence Cancer Institute (Westside), Portland
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年10月13日 · NCT06293898Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Kaiser Permanente Northwest, Portland
招募中2 期
18 Minutes · 所有性别 · 更新于 2026年10月9日 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Kaiser Permanente Northwest, Portland
- 以及另外 1 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月9日 · NCT06616584Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Northwest Cancer Specialists, P.C, Happy Valley
- Northwest Cancer Specialists, P.C., Portland
- Northwest Cancer Specialists, P.C, Tigard
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月8日 · NCT07222566The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
招募中1/2 期
12 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04585750A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Providence Portland Medical Center ( Site 0043), Portland
- Providence Oncology and Hematology Care Clinic - Westside ( Site 0059), Portland
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07286149A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Portland
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT07127874A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Local Institution - 0052, Portland
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT06618287Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- USOR - Oncology Associates of Oregon, P.C, Eugene
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT06343402Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Legacy Mount Hood Medical Center, Gresham
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Legacy Meridian Park Hospital, Tualatin
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Providence Portland Medical Center, Portland
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月15日 · NCT05652686Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
- Willamette Valley Cancer Institute and Research Center, Eugene
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年7月9日 · NCT07315113Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Oregon Health and Science University, Portland
招募中2 期
18 至 70 岁 · 所有性别 · 更新于 2026年6月26日 · NCT04614103Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Providence Newberg Medical Center, Newberg
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Willamette Falls Medical Center, Oregon City
- 以及另外 4 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月3日 · NCT05642572MYLUNG Consortium Part 3: Observational Study
- Willamette Valley Cancer Institute and Research Center, Eugene
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年5月18日 · NCT05885698LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Providence Newberg Medical Center, Newberg
- Providence Willamette Falls Medical Center, Oregon City
- Providence Portland Medical Center, Portland
- 以及另外 1 项
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年1月9日 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Oregon Health & Science University, Portland
招募中观察性研究
50 岁及以上 · 所有性别 · 更新于 2025年8月5日 · NCT06122077数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。